Background {#Sec1}
==========

Diabetes is one of the most important epidemic diseases of this century. The global prevalence of type 2 diabetes is increasing worldwide as a result of population ageing \[[@CR1]\], rising rates of overweight and obesity in adults as well as youth \[[@CR2]\], and reduced risk of mortality among patients with diabetes \[[@CR3]\]. The number of people with diabetes has more than doubled over the past three decades in nearly every nation of the world \[[@CR4]\]. In 2014, the global prevalence of diabetes was estimated to be 9 % among adults older than 18 years old \[[@CR5]\]. It has been projected that there will be 366 million adults with diabetes in 2030 \[[@CR6]\] and, despite recent declines in mortality, diabetes will be the seventh leading cause of death in 15 years \[[@CR7]\], making it one of the most important public health challenges to all nations \[[@CR8]\].

The major burden of diabetes is now taking place in developing rather than in developed countries, and 80 % of patients with diabetes live in less developed areas \[[@CR8]\]. All the Latin American countries have undergone rapid demographic, epidemiological and nutritional transitions \[[@CR9]\], which strongly contributed to the increasing prevalence of diabetes. Brazil is one of the most important examples of this alarming problem in less developed societies with the fourth largest number of people with type 2 diabetes \[[@CR10]\]. In the South and Central America region, 8.0--11.3 % of the adult population have diabetes. Of these, 39.0 % are undiagnosed. Moreover, Brazil has the highest number of people with diabetes in the region. In 2015, in Latin America, almost 250,000 adults died as a result of diabetes, of which half of the deaths occurred in Brazil \[[@CR11]\]. The International Diabetes Federation estimated the prevalence of diabetes in Brazil to be 10.3 % in 2012 \[[@CR12]\], which represents a gradual increase over the past three decades.

This rising diabetes prevalence has translated into a 60 % increase in the attributable risk ratio for cardiovascular diseases associated with diabetes \[[@CR13]\]. However, there is a lack of nationwide prevalence data over time in most emerging countries. In Brazil, although several cross-sectional analyses have been conducted to identify the prevalence of diabetes \[[@CR9]\], no strong and consistent data is available to evaluate the trends over time. In this study, based on the hypothesis of increasing diabetes prevalence over decades and potential regional differences, we sought to investigate existing data sources on the prevalence of diabetes in Brazil and estimate the prevalence trends of diabetes for the last three decades in the adult Brazilian population through a systematic review with meta-analysis of observational studies.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

A comprehensive literature search was conducted to identify articles containing information on diabetes prevalence in Brazil. Two reviewers independently searched in five different databases (PubMed, Cochrane Library, EMBASE, LILACS and SciELO). Search strategies were tested to find the appropriate medical subject heading terms for "Diabetes Mellitus", "Brazil" and its regions, and "Prevalence". The complete PubMed literature search strategy is described in the Additional file [1](#MOESM1){ref-type="media"}: Table S1. No language or age restrictions were applied. A manual search of the references of review articles, key publications, and abstracts from the two past years of the main national related meetings was also performed. All potentially eligible studies were considered for review. Duplicate data were excluded. The software EndNote version X6 (Thomson Reuters, New York, NY) was used for references selection management.

Study selection {#Sec4}
---------------

Additional file [2](#MOESM2){ref-type="media"}: Figure S1 shows the flow diagram of the studies included in the meta-analysis. Two independent and previously trained investigators performed the first titles and abstracts screening. All the selected studies were retrieved for full-text evaluation. We included all publications providing information on type 2 diabetes and our aimed end-point: prevalence, based on population-based cross-sectional and baseline of cohort studies among participants aged 18 years or older published between January 1980 and December 2015. Studies in which the sampling was not random or included less than 300 persons were excluded. Studies that assessed only specific subgroups not representative of its geographical strata were considered ineligible. Studies that included women or men only were considered eligible and were included only for analyses by gender. A third investigator solved disagreements between reviewers.

Data extraction and assessment of study quality {#Sec5}
-----------------------------------------------

Two reviewers separately evaluated the selected studies for data capture. The data were entered in a pretested Microsoft Office Excel™ spreadsheet based on the Strengthening in Epidemiology Statement (STROBE) checklist \[[@CR14], [@CR15]\]. The absolute rather than relative value of each variable was obtained. Any discordance between the data extracted was discussed until consensus was reached.

All studies were addressed for their capability to appropriately respond to our research question, as well as for selection, measurement, and analysis biases. Selection biases were defined by 20 % or more of refuses to participate in the study and by studies that used telephone calls as the only method for patient selection and interviews. Measurement bias was characterized based on diabetes diagnosis criteria: self-reported or measured. Analysis bias was defined as when a study did not consider the design effect to estimate the diabetes prevalence. Data regarding how the study handled missing data were also obtained. Sensitivity analyses were performed as pre-established to deal with potential study biases.

Statistical analysis {#Sec6}
--------------------

Random effect models were used to calculate all point estimates and their 95 % confidence interval (95 % CI), as well as to estimate the prevalence of diabetes for the general population. Sensitivity analyses were performed by sex, decades, macro-region, and diagnostic criteria. Logit transformation was used to handle distribution asymmetry related to different prevalence measures. Continuity correction was used for adjustment when a discrete distribution was approximated by a continuous distribution. Prevalence was weighted by the inverse variance of logit. Pooled values were then converted to prevalence. Chi square was used to determine differences in prevalence rates among different decades. The Cochran Chi square and *I*^*2*^ test were used to evaluate statistical heterogeneity and consistency among the studies, and a value of *p* = 0.10 was used for significance.

Statistical analyses were performed using Stata version 12.1 (StataCorp LP, College Station, TX). MetaXL (EpiGear International, Sunrise Beach, Australia), an Excel comprehensive program for meta-analysis was used to build forest plots. Before start any study procedure, this study was registered \[[@CR16]\] at PROSPERO, an international database of prospectively registered systematic reviews in health and social care, under the registration number of CRD42014010602.

Results {#Sec7}
=======

Synthesis of data {#Sec8}
-----------------

The search retrieved 2522 articles from January 1980 to December 2015, of which 496 were duplicates and were excluded. Additional 1909 articles were removed based on title and abstracts; 117 full-text articles were assessed for eligibility, of which 40 met all the inclusion criteria. Manual search retrieved other ten articles, totalizing 50 studies (1,393,637 individuals) that were included in the final analyses. The flowchart of studies selection is presented in Fig. [1](#Fig1){ref-type="fig"}. Three different patterns for diabetes diagnosis were identified: self-report, fasting glucose, and complex diagnosis \[e.g. fasting glucose + oral glucose tolerance test (OGTT) + self-report\]. The characteristics of the included studies by diagnosis criteria and method of assessment are described in Table [1](#Tab1){ref-type="table"}.Fig. 1Forest plot representing diabetes prevalence rates by self-reported diagnosis and decadesTable 1Characteristics of the included studies by type of diagnosisStudyFinal year of data collectionType of studySample sizeWomen (%)Age criterion for study entry (years)City, state, or regionSelf-reportedSelf-reported diagnosis Almeida et al. \[[@CR17]\]1997Cross-sectional20,28745.730--69Juiz de Fora, RJPersonally Barbosa et al. \[[@CR18]\]2003Cross-sectional83559.7\>18São Luiz, MAPersonally Borges et al. \[[@CR19]\]2006Cross-sectional97257.020--69Pelotas, RSPersonally Capilheira et al. \[[@CR20]\]2003Cross-sectional310056.6\>20Pelotas, RSPersonally Carvalhaes et al. \[[@CR21]\]2005Cross-sectional141061.4\>18Botucatu, SPBy phone Coeli et al. \[[@CR22]\]2001Cross-sectional250658.8\>30Rio de Janeiro, RJPersonally Correia et al. \[[@CR23]\]2007Cross-sectional6431100.020--49CearáPersonally Costa et al. \[[@CR24]\]2005Cross-sectional19,25257.1\>25Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Costa et al. \[[@CR25]\]2000Cross-sectional1968--20--69Pelotas, RSPersonally Francisco et al. \[[@CR26]\]2008Cross-sectional263656.7\>18Campinas, SPPersonally Freitas et al. \[[@CR27]\]1998Cross-sectional217,709--\>18Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Freitas et al. \[[@CR27]\]2003Cross-sectional254,870--\>18Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Freitas et al. \[[@CR27]\]2008Cross-sectional271,677--\>18Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Fuchs et al. \[[@CR28]\]2005Cross-sectional1007100.0\>18Porto Alegre, RSPersonally Gigante et al. \[[@CR29]\]1994Cross-sectional103556.0\>20Pelotas, RSPersonally Iser et al. \[[@CR30]\]2014Cross-sectional60,202--\>18Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Longo et al. \[[@CR31]\]2007Cross-sectional202261.520--59Lages, SCPersonally Machado et al. \[[@CR32]\]2005Cross-sectional377100.045--64Belo Horizonte, MGPersonally Machado et al. \[[@CR33]\]2011Cross-sectional622100.0\>50Campinas, SPPersonally Monteiro et al. \[[@CR34]\]2003Cross-sectional212259.7\>18São Paulo, SPBy phone Moreira et al. \[[@CR35]\]1991Cohort98255.7\>18Porto Alegre, RSPersonally Munhoz et al. \[[@CR36]\]2012Cross-sectional292558.9\>20Pelotas, RSPersonally Peixoto et al. \[[@CR37]\]2005Cross-sectional200262.4\>18Goiânia, GOBy phone Pinheiro et al. \[[@CR38]\]2006Cross-sectional242070.0\>40Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Schellini et al. \[[@CR39]\]2007Cross-sectional469063.6\>30São PauloPersonally Schmidt et al. \[[@CR40]\]2006Cross-sectional54,36960.8\>18Five regions: North, Northeast, Midwest, Southeast, SouthBy phone Theme-Filha et al. \[[@CR41]\]2003Cross-sectional5000--\>18Five regions: North, Northeast, Midwest, Southeast, SouthPersonally Vianna et al. \[[@CR42]\]2010Cross-sectional211257.1\>20Pelotas, RSPersonally VIGITEL \[[@CR43]\]2007Cross-sectional54,25160.3\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR44]\]2008Cross-sectional54,35360.6\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR45]\]2009Cross-sectional54,36760.7\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR46]\]2010Cross-sectional54,33961.8\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR47]\]2011Cross-sectional54,14458.2\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR48]\]2012Cross-sectional45,44861.7\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR49]\]2013Cross-sectional52,92961.7\>1826 Brazilian capitals and Distrito FederalBy phone VIGITEL \[[@CR50]\]2014Cross-sectional40,85362.0\>1826 Brazilian capitals and Distrito FederalBy phoneFasting glucose diagnosis Cipullo et al. \[[@CR51]\]2005Cross-sectional171751.2\>18São José do Rio Preto, SPFasting capillary glucose Makdisse et al. \[[@CR52]\]2004Cross-sectional115953.3\>18Five regions: North, Northeast, Midwest, Southeast, SouthFasting capillary glucose Nunes Filho et al. \[[@CR53]\]2006Cross-sectional35350.720--59Luzerna, SCFasting glucose Passos et al. \[[@CR54]\]1997Cross-sectional231059.0\>18Bambuí, MGFasting glucose Rodrigues et al. \[[@CR55]\]2000Cross-sectional134652.125--64Vitória, ESFasting capillary glucose Schaan et al. \[[@CR56]\]2000Cross-sectional99252.6\>20Rio Grande do SulFasting glucose Souza et al. \[[@CR57]\]2001Cross-sectional103951.0\>18Campos dos Goytacazes, RJFasting glucoseComplex diagnosis Bosi et al. \[[@CR58]\]2008Cross-sectional111664.530--79São Carlos, SPCapillary glycemia \<200 mg/dL → OGTT Malerbi et al. \[[@CR59]\]1988Cross-sectional21,84759.030--69Five regions: North, Northeast, Midwest, Southeast, SouthCapillary glycemia \<200 mg/dL → OGTT Moraes et al. \[[@CR60]\]2007Cross-sectional2182--\>30Ribeirão Preto, SPCapillary glycemia \<200 mg/dL → OGTT Oliveira et al. \[[@CR61]\]1989Cross-sectional205157.230--69Rio de Janeiro, RJCapillary glycemia → OGTT Rodrigues Júnior. et al. \[[@CR62]\]2011Cross-sectional142957.930--69Campo Grande, MSCapillary glycemia \<200 mg/dL → OGTT\
OGTT \>200 mg/dL → diabetes\
Capillary glycemia \>200 mg/dL → diabetes Schmidt et al. \[[@CR63]\]2010Cohort15,10554.435--74Northeast, Southeast, South.Self-report or fasting glycemia ≥126 mg/dL or OGTT ≥200 mg/dL or HbA1c ≥6.5 % Torquato et al. \[[@CR64]\]1997Cross-sectional147366.530--69Ribeirão Preto, SPCapillary glycemia → OGTT

A meta-analysis was conducted according to the diagnosis pattern. Prevalence rates are presented in Figs. [1](#Fig1){ref-type="fig"} (self-reported), [2](#Fig2){ref-type="fig"} (fasting glucose) and [3](#Fig3){ref-type="fig"} (complex diagnosis), respectively. The prevalence of diabetes was 5.6 % (95 % CI 5.0--6.3) by self-report, 6.6 % (95 % CI 4.8--8.9) by fasting glucose, and 11.9 % (95 % CI 7.7--17.8) by complex diagnosis. In trend analyses, we observed an increase in the prevalence of diabetes in studies using a self-reported diagnosis \[3.2 % (95 % CI 2.6--4.1) in the 1990s, 5.7 % (95 % CI 5.1--6.4) in the 2000s, and 6.9 % (95 % CI 6.2--7.6) in the 2010s\] and studies using a complex diagnosis \[7.4 % (95 % CI 7.1--7.7) in the 1980s, 12.1 % (95 % CI 10.5--13.8) in the 1990s, 14.5 % (95 % CI 13.1--16.0) in the 2000s, and 15.7 % (95 % CI 9.8--24.3) in the 2010s\]. Only one study evaluated the prevalence of diabetes by fasting glucose in the 1990s (10.3 %; 95 % CI 9.1--11.6); the other six studies were conducted in the 2000s (6.0 %; 95 % CI 4.2--8.6). High statistical heterogeneity was identified in all analyses (data presented in Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}).Fig. 2Forest plot representing diabetes prevalence rates by fasting glucose diagnosis and decadesFig. 3Forest plot representing diabetes prevalence rates by complex diagnosis and decades

In comparison to males, a female preponderance with regard to prevalence of diabetes was seen in this study in all decades and diagnosis criteria. Trends for the last three decades of diabetes prevalence by sex and decades are presented in Additional file [3](#MOESM3){ref-type="media"}: Figure S2 (self-reported), Additional file [4](#MOESM4){ref-type="media"}: Figure S3 (fasting glucose) and Additional file [5](#MOESM5){ref-type="media"}: Figure S4 (complex diagnosis). Prevalence rates of diabetes and their 95 % CI by sex, age group, regions, and adjustment to the design effect are presented in Table [2](#Tab2){ref-type="table"}. The data presented in this table shows that the prevalence of diabetes was similar among the five different Brazilian macro-regions, and higher in older people. When analyses were adjusted to the design effect, the prevalence of diabetes was lower than the prevalence observed in not adjusted analyses.Table 2Subgroup meta-analysis of diabetes prevalence in Brazilian adults by diagnosis type and sexVariablesOverallFemaleMaleN% (95 % CI)*I* ^2^ %N% (95 % CI)*I* ^2^ %N% (95 % CI)*I* ^2^ %Self-reported Age group (years)  20--6955.1 (2.6--9.8)9945.1 (3.3--7.8)9822.7 (0.7--9.1)99  \>18235.5 (4.8--6.3)100216.1 (5.5--6.9)99205.0 (4.2--6.0)99  \>3037.2 (4.8--10.6)9749.0 (4.8--16.3)9836.0 (3.7--9.7)92 Region  South86.2 (5.4--7.1)7857.3 (6.9--7.7)035.5 (4.8--6.4)0  Southeast65.0 (2.7--8.9)9977.4 (4.7--11.6)9763.9 (1.9--8.0)99  Midwest14.4 (3.6--5.4)--14.4 (3.4--5.7)--14.3 (3.1--6.0)--  Northeast15.1 (3.8--6.9)--14.7 (4.2--5.3)--------  Multiples/national155.7 (4.9--6.8)100155.8 (5.0--6.7)100155.2 (4.2--6.3)100 Adjusted^a^  Yes155.3 (4.5--6.2)99165.7 (4.9--6.5)99164.5 (3.7--5.4)99  No165.9 (4.4--7.9)99137.4 (5.4--9.9)9995.6 (3.2--9.5)99 Overall*31*5.7 (5.1--6.4)100296.3 (5.7--7.1)100254.9 (4.1--5.7)99Fasting glucose Age group (years)  20--6923.6 (1.7--7.3)7622.0 (0.3--12.9)7625.1 (3.8--6.8)0  \>1856.0 (4.7--7.6)9339.5 (6.5--13.7)8.739.0 (6.3--12.7)83 Region  South25.6 (1.0--25.8)9623.2 (0.1--42.9)9027.6 (2.4--21.4)89  Southeast46.4 (4.3--9.5)9436.7 (3.4--12.5)9436.8 (4.9--9.3)73  Multiples/national17.0 (5.7--8.6)-------------- Adjusted^a^  Yes16.0 (4.7--7.6)--15.7 (4.0--8.0)--16.3 (4.5--8.8)--  No66.7 (4.7--9.4)9447.2 (4.1--12.3)9247.5 (4.9--11.4)86 Overall76.6 (4.8--8.9)9456.8 (4.2--11.0)9257.3 (5.1--10.3)84Complex diagnosis Age group (years)  30--6949.4 (7.0--12.6)969.6 (7.2--12.5)9349.0 (6.4--12.4)92  Others^b^316.0 (12.5--20.4)9616.3 (15.7--17.1)016.6 (11.1--24.1)95 Region  Southeast411.6 (8.4--15.7)95412.8 (8.9--17.2)94410.7 (6.7--16.7)93  Midwest112.3 (10.7--14.1)--112.1 (10.0--14.4)--112.6 (10.2--15.5)--  Multiples/national212.3 (4.5--29.5)100211.4 (3.4--21.2)100213.3 (4.1--35.8)100 Adjusted^a^  Yes611.5 (6.4--17.7)100611.5 (7.5--16.2)99611.0 (5.9--19.5)99  No115.0 (13.6--16.6)--117.0 (15.2--18.9)--116.6 (13.9--19.6)-- Overall711.9 (7.7--17.8)100712.2 (8.4--16.6)99*7*11.7 (6.8--19.3)99Complex diagnosis: OGTT + fasting glucose + self-reported, e.g^a^Adjustment to the design effect^b^Studies (age): Bosi et al. \[[@CR58]\] (30--79); Moraes et al. \[[@CR60]\] (\>30) and Schmidt et al. \[[@CR63]\] (35--74)

Quality of studies {#Sec9}
------------------

Additional file [6](#MOESM6){ref-type="media"}: Figure S5 summarizes data regarding quality of studies. Most studies were based on cross-sectional design (49 studies, 96 %). Three different patterns of diabetes diagnosis were identified and included in this analysis: self-report (36 studies, 72 %), fasting glucose (7 studies, 14 %), and complex diagnosis (7 studies, 14 %). Sample sizes varied substantially with a mean of 27.521 people. The mostly used design was cluster sampling (45 studies, 90 %), and sample size calculation was well described in 42 studies (84 %). Most studies were developed only in or including data from Southeast and Southern Brazil (35 studies, 70 % and 30 studies, 60 %, respectively), and 25 studies (50 %) included data from rural areas. Most studies did not have selection bias with potential to compromise internal validity (32 studies, 64 %), as well as analysis bias (43 studies, 86 %); however, only ten studies (20 %) appropriately described handling of missing data.

Discussion {#Sec10}
==========

Decades ago, the global epidemic of diabetes was predicted by epidemiologists who observed large and rapid increases in the prevalence of type 2 diabetes related to Western lifestyle \[[@CR65]\]. Over time, the burden of diabetes has taken place in developing rather than in developed countries \[[@CR66]\]. In the present systematic review with meta-analysis of cross-sectional and baseline of cohort studies, which included more than one million individuals, it was possible to estimate the prevalence of diabetes in Brazil by decades, sex, macro-region, diagnosis criteria, and methods of assessment. Studies based on a complex diagnosis showed a high prevalence of diabetes in Brazilian adults (11.9 %), with a progressive increase in the last 35 years. This trend was also apparently observed in studies based on self-reported diagnosis.

The prevalence of diabetes in Brazil by self-reported method was lower than the other methods used in this study (complex diagnosis and fasting glucose); however, it was observed a progressive increase in prevalence for all detection methods in the last 35 years. This finding may be, in part, due to greater access to diagnostic testing \[[@CR67]\], as well as the recognition of different diagnostic criteria tests for diabetes diagnosis \[[@CR68]\]. A same telephone survey platform, which yearly evaluates diabetes prevalence in Brazil, identified an increase in the overall prevalence of diabetes from 6.3 to 8 % in just 5 years, a 21 % jump \[[@CR46], [@CR50]\].

Moreover, the diagnosis criteria for diabetes based on OGTT and fasting glucose became broader over time, which may differentially identify people without previous diagnosis as having diabetes \[[@CR69]\]. It may explain, to some extent, the progressive increase in diabetes prevalence, as different biomarkers and definitions for diabetes may provide different estimates of population prevalence. Different biomarkers have been used to define diabetes, including fasting glucose, OGTT, and, more recently, HbA1c \[[@CR69]\]. In this meta-analysis, only one study included HbA1c as diagnosis criteria for diabetes \[[@CR40]\]. Results showed that approximately 10 % of cases were diagnosed only by HbA1c method, which can help to explain the high prevalence found. In this study, the prevalence of diabetes remained similar after adjustment by gender, age, skin color, weight status, and education level \[[@CR40]\]. Population-based health surveys in different countries and at different times have also used different biomarkers and criteria for diabetes diagnosis, which define diabetes differently. This variety of biomarkers and definitions creates a challenge in consistently analyzing diabetes prevalence over time. In a large international pooled analysis of population-based examination surveys, it was found that the use of these different biomarkers and definitions can lead to different estimates of population prevalence of diabetes, with the highest prevalence observed when diabetes was defined based on fasting glucose or OGTT \[[@CR69]\].

Although changing definitions could result in variations in diabetes prevalence over time, it doesn't underlie the global increase in diabetes. As obesity is the most important risk factor for type 2 diabetes, its observed increase also influences the current trend in diabetes prevalence. Some studies suggest that more than 80 % of cases of type 2 diabetes can be attributed to obesity, which may also account for many diabetes-related deaths \[[@CR70], [@CR71]\]. The increases in the prevalence of type 2 diabetes, especially in older adults, may also reflect the reduction in major complications and mortality related to diabetes. Between 1988 and 2010, the largest increase in diabetes prevalence in the United States was observed in older adults (≥65 years), and only in this age group this increase remained significant after adjustment for body mass index or waist circumference \[[@CR72]\]. Furthermore, the incidence of diabetes has been stable in the last years \[[@CR73]\]. At the same time, the rates of the major diabetes-related complications, especially acute myocardial infarction, have declined \[[@CR74]\]. In Brazil, the mortality related to diabetes decreased from 1996 to 2011, likely due to better and earlier treatment of the disease, given that the prevalence of diabetes continues to increase. This reduction was approximately twice larger in women (30 vs. 14 %) over 15 years, suggesting a possible role in the higher prevalence observed for this gender \[[@CR3]\]. Possible reasons for the declines in mortality in Brazil over this period include the expanded public health system, especially in terms of primary care, with national programs focused on diabetes \[[@CR75], [@CR76]\], organization of emergency care facilities, and hot line systems for diabetes support \[[@CR75]\].

In this study, we identified a pronounced female preponderance in diabetes prevalence in all decades, using different diagnosis criteria and methods of assessment. This finding is consistent with those observed in other studies, in which sex-related differences in genetics and lifestyle may lead to differences in the risk of developing diabetes and, in consequence, differences in the prevalence of this condition by sex \[[@CR77]\]. In Brazil, a comprehensive literature review summarized the prevalence of diabetes through nine studies \[[@CR9]\]. In this study, women were more likely than men to report having diabetes. Although this could be easily explained by the fact that higher incidence of diabetes is related to more frequently reported prevalence of diabetes, this finding may also reflect higher use of medical care by women and therefore increased likelihood of being diagnosed. However, this is not a consensus in the literature. Although previous studies in Brazil have found similar results \[[@CR63]\], according to the Centers for Disease Control and Prevention, from 1980 to 1998, the age-adjusted diabetes prevalence by sex was similar in the United States, and, from 1999 on, the rate for males began to increase at a faster rate than that for females \[[@CR78]\]. More studies controlling for lifestyle differences may help to better understand these findings.

The present study has some limitations. First, the lack of adjustment of some studies for design effect may compromise accuracy of estimate confidence intervals. Moreover, the different assessment methods for diabetes, changes in diagnosis criteria over time, and high heterogeneity found among the studies limit the interpretation of our results. Also, the poor coverage of the evidence base in many Brazilian regions restricts evaluation for obtaining the national diabetes prevalence over time. Our projections for diabetes prevalence trends for the last three decades are relied on demographic statistics, which might not be accurate for many regions and populations. As a result, our findings should not be considered an appropriate equivalent of a nationwide prevalence study. Also, specific therapies and better social and medical care may reduce direct and indirectly associated mortality and increase prevalence. Further studies in all five Brazilian macro-regions should be required to take into account potential racial, cultural, and socioeconomic diversity of this nation as a whole.

In conclusion, despite the high heterogeneity, this systematic review with meta-analysis showed a high prevalence of diabetes in Brazilian adults over time, with a progressive increase in the last 35 years. These findings may be, in part, associated with improvement in access to health services in the same period. Nevertheless, this study has important epidemiological implications. Our findings reinforce the significant rise in the prevalence of diabetes, which may result in heavy health burden associated to this disorder and its related complications. Based on our results, further studies are necessary to better understand the factors associated to the increasing diabetes prevalence in Brazil, which may help to shape future prevention programs.
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